Asiapac Books

NEXTGEN Group Revolutionizes Technology Services Across Asia with Unique Collaborative Model

Retrieved on: 
Monday, November 13, 2023
Economics, IP, Asiapac Books, IBM, Intellectual property, Marketing, Software as a service, Azure, Environment, Growth, Orienspace, AWS, Sales, Arms industry, Video game, Software, CrowdStrike, Arista, Oracle

SYDNEY, Nov. 13, 2023 /PRNewswire/ -- NEXTGEN Group (NEXTGEN), a leading Australian technology services company, is transforming the Asia IT industry with its innovative collaborative service model.

Key Points: 
  • SYDNEY, Nov. 13, 2023 /PRNewswire/ -- NEXTGEN Group (NEXTGEN), a leading Australian technology services company, is transforming the Asia IT industry with its innovative collaborative service model.
  • NEXTGEN is pioneering fresh approaches to distribution, digital marketing, demand generation, and market entry support for enterprise software, cloud, and supporting infrastructure vendors.
  • This unique combination of strategy, platforms, technology, intellectual property, and people are now helping the technology channel to increase their speed to revenue and their growth opportunities in the AsiaPac region.
  • We have now matured this model and our approach sets us apart in the market," said John Walters, CEO of NEXTGEN Group.

Morningstar, Inc. Reports Third-Quarter 2023 Financial Results

Retrieved on: 
Wednesday, October 25, 2023
Growth, Investment management, DBRS, ADP, LCD, Supplement, Asiapac Books, ESG, Investment, Corporation, Form, GAAP, ABS, AUMA, Writing, PitchBook Data, Balance sheet, Retirement, Acquisition, Capital allocation line, API, Intelligence, S&P Global, Table, CMBS, Intelligence engine, Letter, IPX, Video game, Financial adviser, Clothing, Music, Security (finance), Real estate, Life insurance, Commercial property, Bank, Tourism, Cryptocurrency

Starting with the Company's Form 10-Q for the quarter ended Sept. 30, 2023, the Company will begin to report multiple segments.

Key Points: 
  • Starting with the Company's Form 10-Q for the quarter ended Sept. 30, 2023, the Company will begin to report multiple segments.
  • The Company's quarterly shareholder letter provides more context on its quarterly results and business and can be found at shareholders.morningstar.com.
  • Headcount as of Sept. 30, 2023 decreased 1.3% compared to Sept. 30, 2022, and 4.6% sequentially from June 30, 2023 to 11,566.
  • Going forward, the Company is also evaluating how best to communicate to investors under the new segment reporting framework in future press releases reporting financial results.

OWIT Global Announces O/DIEM, a Strategic Platform for the Insurance Industry that Supports Digitalization Process and Clean Data Across the Value Chain

Retrieved on: 
Thursday, September 7, 2023
Technology, Insurance, Consulting, Professional Services, Small Business, Software, Networks, Internet, Data Management, TPA, MGA, Asiapac Books, Gamma globulin, Sales

OWIT Global (OWIT), the leader in cloud-based insurance-specific microservices architected solutions to digitalize the global insurance industry, announces the release of O/DIEM , OWIT’s Digitalization Insurance Enterprise Management Platform.

Key Points: 
  • OWIT Global (OWIT), the leader in cloud-based insurance-specific microservices architected solutions to digitalize the global insurance industry, announces the release of O/DIEM , OWIT’s Digitalization Insurance Enterprise Management Platform.
  • O/DIEM is a strategic platform for the insurance industry that supports the industry’s need for innovative processes and clean data from internal and external sources.
  • Over the years, insurers have implemented various software solutions to support multiple lines of business and operational requirements.
  • “With O/DIEM, the industry now has an alternative solution to enable direct access to the source data as a first step in digitalizing the end-to-end process.”

OWIT Global Successfully Completes SOC 2® Type II Examination

Retrieved on: 
Thursday, August 17, 2023
Technology, Mobile, Wireless, Insurance, Finance, Consulting, Small Business, Banking, Professional Services, Other Technology, Software, Networks, Internet, Hardware, Data Management, System and Organization Controls, ISO, Asiapac Books, Service, SOC, Turnkey, Certification, SOC 2, System, Audit

OWIT Global (OWIT), the leader in cloud-based insurance-specific microservices architected solutions to digitalize the global insurance industry, today announced that it has successfully completed the System and Organization Controls SOC 2® Type II examination for the Bordereaux Management Solution.

Key Points: 
  • OWIT Global (OWIT), the leader in cloud-based insurance-specific microservices architected solutions to digitalize the global insurance industry, today announced that it has successfully completed the System and Organization Controls SOC 2® Type II examination for the Bordereaux Management Solution.
  • OWIT retained international business advisory firm Marcum LLP for its SOC 2 external examination.
  • OWIT selected Marcum LLP after an intensive search based on their reputation as a leading risk advisory and compliance firm.
  • Upon completion of the audit, OWIT received a Service Auditor’s Report with an unqualified opinion demonstrating that their policies, procedures, and infrastructure meet or exceed the stringent SOC 2 criteria.

Sompo International appoints Paul O’Neill to lead Commercial Lines Insurance business in Asia Pacific

Retrieved on: 
Thursday, January 5, 2023
Asiapac Books, Commercial, Chemical substance, Risk assessment, Energy, Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science, International finance, Management, Sompo Japan Nipponkoa Insurance, Insurance

PEMBROKE, Bermuda, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Sompo International, a leading global provider of commercial and consumer property and casualty (re)insurance, announced today that Paul O’Neill has been appointed President of Commercial Lines, Insurance, Asia Pacific reporting to Julian James, Sompo International’s CEO, Global Markets, Commercial P&C and Daniel Neo, CEO, Asia Pacific, Sompo International.

Key Points: 
  • PEMBROKE, Bermuda, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Sompo International, a leading global provider of commercial and consumer property and casualty (re)insurance, announced today that Paul O’Neill has been appointed President of Commercial Lines, Insurance, Asia Pacific reporting to Julian James, Sompo International’s CEO, Global Markets, Commercial P&C and Daniel Neo, CEO, Asia Pacific, Sompo International.
  • He will start in the new role this month and be based in Singapore.
  • Mr. O’Neill will be accountable for developing and driving the strategy for Sompo International’s commercial business across Asia Pacific, excluding Japan, to help meet the company’s ambitious growth goals.
  • Prior to that, he was Chief Underwriting Officer Specialty at AGCS and Member of the Board of Management.

STALICLA to in-license SFX-01 from Evgen for neurodevelopment disorder indications

Retrieved on: 
Monday, October 10, 2022
Quality of life, Medicine, Asiapac Books, Autism spectrum, Growth, Schizophrenia, ASD, EVG, Glioma, NDD, Neurodevelopmental disorder, Patient, Drug development, AIM, Orphan drug, Precision medicine, Lists of diseases, Company, Disorder, Mike Evgen, Safety, London, Psychiatry, FDA, DEPI, London Stock Exchange, Pharmaceutical industry, Medical device

GENEVA, Oct. 10, 2022 /PRNewswire/ -- STALICLA SA, a precision neuroscience clinical stage biotech, advancing the first precision medicine platform (DEPI) for patients with Neurodevelopmental Disorders (NDDs), today announced the worldwide in-licensing of SFX-01 from Evgen Pharma plc (Evgen) in neurodevelopmental disorders and schizophrenia, with a first indication for a biologically-characterized subgroup of patients with Autism Spectrum Disorder (ASD).

Key Points: 
  • Thanks to DEPI, a proprietary platform aggregating molecular data and human genetic information, STALICLA pushes the frontier of precision medicine further into precision NDDs.
  • DEPI has already reached validation through the clinical identification of biologically defined subgroups of patients with ASD, and their respective candidate treatments.
  • SFX-01 will strengthen STALICLA's pipeline to advance precision medicine for a new subgroup of patient with Autism Spectrum Disorder.
  • Thanks to DEPI, STALICLA identified SFX-01 as the best treatment candidate for its second subgroup of patients, ASD-Phenotype 2.

STALICLA to in-license SFX-01 from Evgen for neurodevelopment disorder indications

Retrieved on: 
Monday, October 10, 2022
Quality of life, Medicine, Asiapac Books, Autism spectrum, Growth, Schizophrenia, ASD, EVG, Glioma, NDD, Neurodevelopmental disorder, Patient, Drug development, Multimedia, AIM, Orphan drug, Precision medicine, Lists of diseases, Company, Disorder, Mike Evgen, Safety, London, Psychiatry, FDA, DEPI, London Stock Exchange, View, Pharmaceutical industry, Medical device

GENEVA, Oct. 10, 2022 /PRNewswire/ -- STALICLA SA, a precision neuroscience clinical stage biotech, advancing the first precision medicine platform (DEPI) for patients with Neurodevelopmental Disorders (NDDs), today announced the worldwide in-licensing of SFX-01 from Evgen Pharma plc (Evgen) in neurodevelopmental disorders and schizophrenia, with a first indication for a biologically-characterized subgroup of patients with Autism Spectrum Disorder (ASD).

Key Points: 
  • Thanks to DEPI, a proprietary platform aggregating molecular data and human genetic information, STALICLA pushes the frontier of precision medicine further into precision NDDs.
  • DEPI has already reached validation through the clinical identification of biologically defined subgroups of patients with ASD, and their respective candidate treatments.
  • SFX-01 will strengthen STALICLA's pipeline to advance precision medicine for a new subgroup of patient with Autism Spectrum Disorder.
  • Thanks to DEPI, STALICLA identified SFX-01 as the best treatment candidate for its second subgroup of patients, ASD-Phenotype 2.

Rheos Capital Works Selects FactSet’s Portware Execution Management System

Retrieved on: 
Thursday, October 6, 2022
Asiapac Books, Efficiency, Workflow, Solution, NYSE, NASDAQ, Twitter, Human rights, Technology, Automation, FDS, FactSet, GLOBE, EMS, Risk management

NORWALK, Conn. and TOKYO, Japan, Oct. 06, 2022 (GLOBE NEWSWIRE) -- FactSet (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading services, announced that Tokyo-based asset manager Rheos Capital Works has deployed FactSets Portware Execution Management System (EMS) firmwide to power its trading workflow.

Key Points: 
  • NORWALK, Conn. and TOKYO, Japan, Oct. 06, 2022 (GLOBE NEWSWIRE) -- FactSet (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading services, announced that Tokyo-based asset manager Rheos Capital Works has deployed FactSets Portware Execution Management System (EMS) firmwide to power its trading workflow.
  • Portware enables traders to analyze, communicate, and execute orders with diverse market participants and liquidity destinations through highly efficient, customized, and automated workflows.
  • Working closely with FactSet, the custom implementation of Portware at Rheos included the integration of our unique workflow requirements, as well as Japanese language support, said Takehiro Okada, head of the trading department at Rheos Capital Works.
  • Rheos Capital Works is an asset management company founded in 2003 based on the management philosophy, To have a positive impact on society as a responsible participant in capital markets".

MDX Technology acquires Iceflow Technology Limited, a low-code/no-code SaaS workflow solution for financial institutions

Retrieved on: 
Wednesday, June 15, 2022
IHS Markit, CTO, Software as a service, KYC, TP ICAP, Technology, CEO, ICE, Asiapac Books, Marex, Royal Bank, Acquisition, TP, HSBC, Pocs, MarketAxess, Royal Bank of Canada, Online shopping

LONDON, June 15, 2022 /PRNewswire/ -- MDX Technology (MDXT) today announces the acquisition of Iceflow Technologies Limited.

Key Points: 
  • LONDON, June 15, 2022 /PRNewswire/ -- MDX Technology (MDXT) today announces the acquisition of Iceflow Technologies Limited.
  • Proof of Concepts (POCs) can be set up within days and deployed very quickly due it being a low-code/no-code SaaS platform.
  • Iceflow has been developed by Graham Denyer, ex-IHS Markit and architect of the original Markit EDM solution, Graham will join MDXT as CTO.
  • "Iceflow is the culmination of 20 years' experience in building financial services workflow solutions.

MDX Technology acquires Iceflow Technology Limited, a low-code/no-code SaaS workflow solution for financial institutions

Retrieved on: 
Wednesday, June 15, 2022
IHS Markit, CTO, Software as a service, KYC, TP ICAP, Technology, CEO, ICE, Asiapac Books, Marex, Royal Bank, Acquisition, TP, HSBC, Pocs, MarketAxess, Royal Bank of Canada, Online shopping

LONDON, June 15, 2022 /PRNewswire/ -- MDX Technology (MDXT) today announces the acquisition of Iceflow Technologies Limited.

Key Points: 
  • LONDON, June 15, 2022 /PRNewswire/ -- MDX Technology (MDXT) today announces the acquisition of Iceflow Technologies Limited.
  • Proof of Concepts (POCs) can be set up within days and deployed very quickly due it being a low-code/no-code SaaS platform.
  • Iceflow has been developed by Graham Denyer, ex-IHS Markit and architect of the original Markit EDM solution, Graham will join MDXT as CTO.
  • "Iceflow is the culmination of 20 years' experience in building financial services workflow solutions.